NEW YORK (GenomeWeb News) – Actar, a part of the Karolinska Institutet innovations system in Sweden, has purchased Corning’s Epic System, which it will use in providing label-free drug screening services.
 
According to Corning, Actar is the first and only company to offer high-throughput, label-free drug screening to academic researchers in Scandanavia and Europe on a fee-for-service basis.
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers have treated an X-linked genetic disease affecting three babies in utero, Stat News reports.

The Associated Press reports that the US Centers for Disease Control and Prevention is beefing up sequencing as a tool to investigate foodborne illnesses.

Researchers have sequenced samples from ancient toilets to study past eating habits and health, NPR reports.

In Nature this week: ash dieback disease fungal genome, and more.